113 related articles for article (PubMed ID: 11678953)
21. Lignocaine with adrenaline: is it as effective as cocaine in rhinological practice?
Kasemsuwan L; Griffiths MV
Clin Otolaryngol Allied Sci; 1996 Apr; 21(2):127-9. PubMed ID: 8735396
[TBL] [Abstract][Full Text] [Related]
22. Intranasal topical local anesthetic and decongestant for flexible nasendoscopy in children: a randomized, double-blind, placebo-controlled trial.
Chadha NK; Lam GO; Ludemann JP; Kozak FK
JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1301-5. PubMed ID: 24158493
[TBL] [Abstract][Full Text] [Related]
23. [Nasal decongestion evaluated by acoustic rhinometry].
Nagano E; Nonaka S
Nihon Jibiinkoka Gakkai Kaiho; 1994 Nov; 97(11):2075-84. PubMed ID: 7529833
[TBL] [Abstract][Full Text] [Related]
24. Attenuation of allergen-evoked nasal responses by local pretreatment with exogenous neuropeptide Y in atopic patients.
Lacroix JS; Mosimann BL
J Allergy Clin Immunol; 1996 Sep; 98(3):611-6. PubMed ID: 8828539
[TBL] [Abstract][Full Text] [Related]
25. Histamine Applied Topically to the Nasal Mucosa Increases the Transmucosal Nitrous Oxide Exchange for the Middle Ear.
Teixeira MS; Alper CM; Martin BS; Cetin S; El-Wagaa JA; Doyle WJ
Ann Otol Rhinol Laryngol; 2017 Apr; 126(4):284-289. PubMed ID: 28103698
[TBL] [Abstract][Full Text] [Related]
26. Role of substance P in the vascular response of nasal mucosa in nasal allergy.
Konno A; Numata T; Terada N; Hanazawa T; Nagata H; Motosugi H
Ann Otol Rhinol Laryngol; 1996 Aug; 105(8):648-53. PubMed ID: 8712637
[TBL] [Abstract][Full Text] [Related]
27. Intranasal beclomethasone reduces allergen-induced symptoms and superficial mucosal eosinophilia without affecting submucosal inflammation.
Baroody FM; Rouadi P; Driscoll PV; Bochner BS; Naclerio RM
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):899-906. PubMed ID: 9517609
[TBL] [Abstract][Full Text] [Related]
28. Substance P induced histamine release from nasal mucosa of subjects with and without allergic rhinitis.
Hanf G; Schierhorn K; Brunnée T; Noga O; Verges D; Kunkel G
Inflamm Res; 2000 Oct; 49(10):520-3. PubMed ID: 11089903
[TBL] [Abstract][Full Text] [Related]
29. [Clinical observation on relation between nasal mucosa contact point and headache].
WANG J; YIN JS; LI JD; YANG L; DUAN YL
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 47(4):317-9. PubMed ID: 22800351
[TBL] [Abstract][Full Text] [Related]
30. Nasal mucociliary clearance after radiation therapy.
Stringer SP; Stiles W; Slattery WH; Krumerman J; Parsons JT; Mendenhall WM; Cassisi NJ
Laryngoscope; 1995 Apr; 105(4 Pt 1):380-2. PubMed ID: 7715382
[TBL] [Abstract][Full Text] [Related]
31. Platelet-activating factor nasal challenge induces nasal congestion and reduces nasal volume in both healthy volunteers and allergic rhinitis patients.
Muñoz-Cano R; Valero A; Roca-Ferrer J; Bartra J; Sanchez-Lopez J; Mullol J; Picado C
Am J Rhinol Allergy; 2013; 27(2):e48-52. PubMed ID: 23562190
[TBL] [Abstract][Full Text] [Related]
32. Nasal septal mucosal contact points: associated symptoms and sinus CT scan scoring.
Bieger-Farhan AK; Nichani J; Willatt DJ
Clin Otolaryngol Allied Sci; 2004 Apr; 29(2):165-8. PubMed ID: 15113304
[TBL] [Abstract][Full Text] [Related]
33. Substance P and nasal secretion in dog, rat, and man.
Petersson G; McCaffrey TV; Malm L
Ann Allergy; 1989 May; 62(5):410-4. PubMed ID: 2470273
[TBL] [Abstract][Full Text] [Related]
34. Capsaicin-desensitization to the human nasal mucosa selectively reduces pain evoked by citric acid.
Geppetti P; Tramontana M; Del Bianco E; Fusco BM
Br J Clin Pharmacol; 1993 Feb; 35(2):178-83. PubMed ID: 8443036
[TBL] [Abstract][Full Text] [Related]
35. [The possibility of using соformulated intranasal drugs after surgical correction of nasal breathing].
Nikiforova GN; Svistushkin VM; Zakharova NM; Shevchik EA; Zolotova AV; Dedova MG
Vestn Otorinolaringol; 2016; 81(1):51-56. PubMed ID: 26977570
[TBL] [Abstract][Full Text] [Related]
36. Increased vascular permeability in rat nasal mucosa induced by substance P and stimulation of capsaicin-sensitive trigeminal neurons.
Lundblad L; Saria A; Lundberg JM; Anggård A
Acta Otolaryngol; 1983; 96(5-6):479-84. PubMed ID: 6195887
[TBL] [Abstract][Full Text] [Related]
37. Reducing the pain of intranasal drug administration.
Antonio C; Zurek J; Creighton P; Johnson K; Heard C
Pediatr Dent; 2011; 33(5):415-9. PubMed ID: 22104710
[TBL] [Abstract][Full Text] [Related]
38. Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids.
Grassin-Delyle S; Buenestado A; Naline E; Faisy C; Blouquit-Laye S; Couderc LJ; Le Guen M; Fischler M; Devillier P
Pharmacol Ther; 2012 Jun; 134(3):366-79. PubMed ID: 22465159
[TBL] [Abstract][Full Text] [Related]
39. Activity of substance P on human skin and nasal airways.
Miadonna A; Tedeschi A; Leggieri E; Lorini M; Qualizza R; Froldi M; Zanussi C
Ann Allergy; 1988 Sep; 61(3):220-3. PubMed ID: 2458061
[TBL] [Abstract][Full Text] [Related]
40. Influence of intranasal sterile isotonic sea water applications on xylometazoline administration: an experimental study in pigs.
Nikolaidis E; Eleftheriadou A; Yiotakis I; Lazaris AC; Agrogianis G; Ferekidou E; Keramaris N; Papalois A; Kandiloros D
Auris Nasus Larynx; 2010 Feb; 37(1):71-6. PubMed ID: 19414231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
